Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

NCT00440726 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Bortezomib
DRUG: Dexamethasone
DRUG: PEG-asparaginase
DRUG: Doxorubicin
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Triple IT Therapy

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium